Media Room
First Quarter 2025
First quarter 2025 results will be reviewed by management during a live audio webcast with the financial community. The presentation will be followed by a Q&A session.
Thursday April 24, 2025
13:00 - 14:30 CET (7:00am – 8:30am EDT)
Press releases
March 28, 2025
Press Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD
March 26, 2025
Press Release: Chlamydia vaccine candidate granted fast track designation by the US FDA
March 25, 2025
Press Release: Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis
Contact Our Media Team
You are a journalist and have a question about Sanofi, please contact the Global Media relations team. Please note the contact details are only for journalists.
Publications
Sustainability Statement 2024 (ESG Report)
XBRL Viewer URD 2024
Registration Document 2024 (in French)
XBRL Viewer 20F 2024